171 related articles for article (PubMed ID: 37511564)
1. Characterization of the Cardiac Structure and Function of Conscious D2.B10-
De Giorgio D; Novelli D; Motta F; Cerrato M; Olivari D; Salama A; Fumagalli F; Latini R; Staszewsky L; Crippa L; Steinkühler C; Licandro SA
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511564
[TBL] [Abstract][Full Text] [Related]
2. The D2.mdx mouse as a preclinical model of the skeletal muscle pathology associated with Duchenne muscular dystrophy.
Hammers DW; Hart CC; Matheny MK; Wright LA; Armellini M; Barton ER; Sweeney HL
Sci Rep; 2020 Aug; 10(1):14070. PubMed ID: 32826942
[TBL] [Abstract][Full Text] [Related]
3. Simvastatin provides long-term improvement of left ventricular function and prevents cardiac fibrosis in muscular dystrophy.
Kim MJ; Bible KL; Regnier M; Adams ME; Froehner SC; Whitehead NP
Physiol Rep; 2019 Mar; 7(6):e14018. PubMed ID: 30912308
[TBL] [Abstract][Full Text] [Related]
4. Natural disease history of the D2
van Putten M; Putker K; Overzier M; Adamzek WA; Pasteuning-Vuhman S; Plomp JJ; Aartsma-Rus A
FASEB J; 2019 Jul; 33(7):8110-8124. PubMed ID: 30933664
[TBL] [Abstract][Full Text] [Related]
5. Preserved Left Ventricular Function despite Myocardial Fibrosis and Myopathy in the Dystrophin-Deficient D2.B10-Dmd
Hayes HM; Angerosa J; Piers AT; White JD; Koleff J; Thurgood M; Moody J; Cheung MM; Pepe S
Oxid Med Cell Longev; 2022; 2022():5362115. PubMed ID: 35340200
[TBL] [Abstract][Full Text] [Related]
6. Exclusive skeletal muscle correction does not modulate dystrophic heart disease in the aged mdx model of Duchenne cardiomyopathy.
Wasala NB; Bostick B; Yue Y; Duan D
Hum Mol Genet; 2013 Jul; 22(13):2634-41. PubMed ID: 23459935
[TBL] [Abstract][Full Text] [Related]
7. Increased plasma lipid levels exacerbate muscle pathology in the mdx mouse model of Duchenne muscular dystrophy.
Milad N; White Z; Tehrani AY; Sellers S; Rossi FMV; Bernatchez P
Skelet Muscle; 2017 Sep; 7(1):19. PubMed ID: 28899419
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular phenotype of the
Szabó PL; Ebner J; Koenig X; Hamza O; Watzinger S; Trojanek S; Abraham D; Todt H; Kubista H; Schicker K; Remy S; Anegon I; Kiss A; Podesser BK; Hilber K
Dis Model Mech; 2021 Feb; 14(2):. PubMed ID: 33619211
[TBL] [Abstract][Full Text] [Related]
9. Chloroquine decreases cardiac fibrosis and improves cardiac function in a mouse model of Duchenne muscular dystrophy.
Hirata T; Baba S; Akagi K; Matsuda K; Umeda K; Adachi S; Heike T; Takita J
PLoS One; 2024; 19(1):e0297083. PubMed ID: 38295120
[TBL] [Abstract][Full Text] [Related]
10. Impairments in left ventricular mitochondrial bioenergetics precede overt cardiac dysfunction and remodelling in Duchenne muscular dystrophy.
Hughes MC; Ramos SV; Turnbull PC; Edgett BA; Huber JS; Polidovitch N; Schlattner U; Backx PH; Simpson JA; Perry CGR
J Physiol; 2020 Apr; 598(7):1377-1392. PubMed ID: 30674086
[TBL] [Abstract][Full Text] [Related]
11. The pan HDAC inhibitor Givinostat improves muscle function and histological parameters in two Duchenne muscular dystrophy murine models expressing different haplotypes of the LTBP4 gene.
Licandro SA; Crippa L; Pomarico R; Perego R; Fossati G; Leoni F; Steinkühler C
Skelet Muscle; 2021 Jul; 11(1):19. PubMed ID: 34294164
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy.
Dahiya S; Givvimani S; Bhatnagar S; Qipshidze N; Tyagi SC; Kumar A
J Immunol; 2011 Sep; 187(5):2723-31. PubMed ID: 21810612
[TBL] [Abstract][Full Text] [Related]
13. Diaphragm degeneration and cardiac structure in mdx mouse: potential clinical implications for Duchenne muscular dystrophy.
Barbin IC; Pereira JA; Bersan Rovere M; de Oliveira Moreira D; Marques MJ; Santo Neto H
J Anat; 2016 May; 228(5):784-91. PubMed ID: 26822140
[TBL] [Abstract][Full Text] [Related]
14. Increased connective tissue growth factor associated with cardiac fibrosis in the mdx mouse model of dystrophic cardiomyopathy.
Au CG; Butler TL; Sherwood MC; Egan JR; North KN; Winlaw DS
Int J Exp Pathol; 2011 Feb; 92(1):57-65. PubMed ID: 21121985
[TBL] [Abstract][Full Text] [Related]
15. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
[TBL] [Abstract][Full Text] [Related]
16. Label-free 3D characterization of cardiac fibrosis in muscular dystrophy using SHG imaging of cleared tissue.
Pichon J; Ledevin M; Larcher T; Jamme F; Rouger K; Dubreil L
Biol Cell; 2022 Mar; 114(3):91-103. PubMed ID: 34964145
[TBL] [Abstract][Full Text] [Related]
17. Cardiac and Skeletal Muscle Pathology in the D2/mdx Mouse Model and Caveats Associated with the Quantification of Utrophin.
Kennedy TL; Dugdale HF
Methods Mol Biol; 2023; 2587():55-66. PubMed ID: 36401024
[TBL] [Abstract][Full Text] [Related]
18. Acute AT
Meyers TA; Heitzman JA; Krebsbach AM; Aufdembrink LM; Hughes R; Bartolomucci A; Townsend D
J Mol Cell Cardiol; 2019 Mar; 128():51-61. PubMed ID: 30664850
[TBL] [Abstract][Full Text] [Related]
19. Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H
Hughes MC; Ramos SV; Turnbull PC; Rebalka IA; Cao A; Monaco CMF; Varah NE; Edgett BA; Huber JS; Tadi P; Delfinis LJ; Schlattner U; Simpson JA; Hawke TJ; Perry CGR
J Cachexia Sarcopenia Muscle; 2019 Jun; 10(3):643-661. PubMed ID: 30938481
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of Wilms' Tumor 1 in epicardial cells increases cardiac fibrosis in dystrophic mice.
Guo Z; Geng M; Huang Y; Han G; Jing R; Lin C; Zhang X; Zhang M; Fan G; Wang F; Yin H
Cell Death Differ; 2022 Oct; 29(10):1928-1940. PubMed ID: 35306537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
